US 11951114
Use of thyroid beta-agonists
granted A61KA61K31/662A61K31/665
Quick answer
US patent 11951114 (Use of thyroid beta-agonists) held by Viking Therapeutics, Inc. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Viking Therapeutics, Inc.
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/662, A61K31/665, A61P, A61P25/00